Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 2/20 | 1.00 |
| ▸ | DRD3 | P35462 | 2/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 1.00 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.97 |
| ▸ | LMNA | P02545 | 3/20 | 0.97 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.74 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.74 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.74 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.74 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.74 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.63 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.55 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.49 |
| ▸ | MITF | O75030 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21451092 | 1.00 | CHRM2 (1.00) | CHRM2ADRA2BDRD3SIGMAR1HRH3 | |
| Tolperisone SCHEMBL17223884 | 1.00 | CHRM2 (1.00) | CHRM2ADRA2BDRD3SIGMAR1HRH3 | |
| Tolperisone SCHEMBL4516510 | 1.00 | CHRM2 (1.00) | CHRM2ADRA2BDRD3SIGMAR1HRH3 | |
| Tolperisone SCHEMBL4780118 | 1.00 | CHRM2 (1.00) | CHRM2ADRA2BDRD3SIGMAR1HRH3 | |
| Tolperisone SCHEMBL872770 | 0.98 | ALDH1A1 (1.00) | CHRM2ADRA2BDRD3SIGMAR1HRH3 | |
| SCHEMBL9172663 | 0.98 | CHRM2 (0.97) | CHRM2ADRA2BDRD3SIGMAR1HRH3 | |
| Tolperisone SCHEMBL15663055 | 0.97 | CHRM2 (0.94) | CHRM2ADRA2BDRD3SIGMAR1HRH3 | |
| Deutolperisone SCHEMBL5371621 | 0.90 | CHRM2 (0.81) | CHRM2ADRA2BDRD3SIGMAR1HRH3 | |
| Tolperisone SCHEMBL5356342 | 0.90 | CHRM2 (0.81) | CHRM2ADRA2BDRD3SIGMAR1HRH3 | |
| SCHEMBL10852535 | 0.88 | CHRM2 (0.78) | CHRM2ADRA2BDRD3SIGMAR1HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2910 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120121747-A | Method for simultaneously measuring tolperisone hydrochloride, methyl hesperidin and vitamin B6 content in Naoluotong capsule | 浙江省食品药品检验研究院(《中国现代应用药学》杂志社) | 2025-06-10 | — | — | CN | claimed |
| CN-120079360-A | Oily sewage adsorbent and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-06-03 | — | — | CN | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-119241531-B | Synthesis process of 6-hydroxy tropinone | 湖州恒远生物化学技术有限公司 | 2025-05-06 | — | — | CN | claimed |
| US-12292363-B2 | Method for preparing biological material having excellent light-transmitting property | RIKEN (JP) | 2025-05-06 | — | — | US | claimed |
| WO-2025062440-A1 | TOPICAL NANO-DISPERSION COMPOSITIONS AND THEIR PREPARATION THEREOF | PULSE PHARMACEUTICALS PVT. LTD (IN) | 2025-03-27 | — | — | WO | claimed |
| CN-119488493-A | Naoluotong capsule and preparation method thereof | 一力制药(罗定)有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119241531-A | Synthesis process of 6-hydroxy tropinone | 湖州恒远生物化学技术有限公司 | 2025-01-03 | — | — | CN | claimed |
| US-20240374769-A1 | LIGHT ACTIVATED CLEANING COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2024-11-14 | — | — | US | claimed |
| WO-2024233595-A1 | LIGHT ACTIVATED CLEANING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2024-11-14 | — | — | WO | claimed |
| EP-0580860-B1 | METHOD OF MANUFACTURING SOLID DISPERSION | NIPPON SHINYAKU CO LTD (JP) | 1997-10-22 | — | — | EP | claimed |
| EP-0273375-B2 | Propiophenone derivatives for treatment of pollakiuria (frequency urination) | HOKURIKU PHARMACEUTICAL (JP) | 1995-05-10 | — | — | EP | claimed |
| EP-0454089-B1 | Percutaneously absorbable eperisone or tolperisone preparation | SEIKISUI CHEMICAL CO LTD (JP) | 1994-08-17 | — | — | EP | claimed |
| US-5252588-A | Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1993-10-12 | — | — | US | claimed |
| US-5073375-A | Monoglyceride or lactic acid ester | SANSHO CO., LTD. (JP) | 1991-12-17 | — | — | US | claimed |
| EP-0454089-A1 | Percutaneously absorbable eperisone or tolperisone preparation | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-10-30 | — | — | EP | claimed |
| US-5059427-A | PHARMACEUTICAL PREPARATION FOR PERCUTANEOUS ADMINISTRATION CONTAINING EPERISONE OR TOLPERISONE OR SALT THEREOF | SANSHO CO., LTD. (JP) | 1991-10-22 | — | — | US | claimed |
| EP-0295411-B1 | PHARMACEUTICAL PREPARATION FOR PERCUTANEOUS ADMINISTRATION CONTAINING EPERISONE OR TOLPERISONE OR A SALT THEREOF | Sansho Co., Ltd. (JP) | 1990-09-05 | — | — | EP | claimed |
| US-4912116-A | Propiophenone derivatives for treatment of pollakiuria (frequency urination) | HOKURIKU PHARMACEUTICAL CO., LTD. (JP) | 1990-03-27 | — | — | US | claimed |
| EP-0295411-A1 | Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or a salt thereof | Sansho Co., Ltd. (JP) | 1988-12-21 | — | — | EP | claimed |